CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 24 enrolled
Drug / intervention
COQUN ORAL FORMULATIONdietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03819491
NCT03819491Phase 1Completed
CompareCT.gov

Bioavailability Study of COQUN ORAL FORMULATION (CoQ10) Administered in Healthy Adults (CoQ10-01)

VISUfarma SpA·interventional·Posted Jan 28, 2019·Updated Sep 6, 2019

In Brief

A Phase 1 clinical trial evaluating COQUN ORAL FORMULATION for Male & Female Healthy Volunteers. Completed, enrolled 24 participants across 1 site.

Detailed Summary

The goal of the study is to evaluate the best dosage for COQUN ORAL FORMULATION in order to reach a level of plasma concentration which might assure its antioxidant effect if taken on a regular basis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMale & Female Healthy Volunteers
CountriesRomania
Collaborators--

Timeline

Phase 1CompletedFinished
20192020202120222023202420252026
First PostedJan 28, 2019
Enrollment StartJun 22, 2018
Primary CompletionAug 29, 2018
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 7.4 years ago

Interventions

COQUN ORAL FORMULATIONdietary

COQUN ORAL FORMULATION is a food supplement based on Coenzyme Q10 MINIACTIVES®